161 related articles for article (PubMed ID: 33853729)
1. Clinical and microbiological characteristics of Eggerthella lenta bacteremia at a Japanese tertiary hospital.
Nagaoka R; Kitagawa H; Koba Y; Tadera K; Hara T; Kashiyama S; Nomura T; Omori K; Shigemoto N; Yokozaki M; Ohge H
J Infect Chemother; 2021 Aug; 27(8):1261-1264. PubMed ID: 33853729
[TBL] [Abstract][Full Text] [Related]
2. Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study.
Ugarte-Torres A; Gillrie MR; Griener TP; Church DL
Clin Infect Dis; 2018 Jul; 67(2):221-228. PubMed ID: 29373647
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility testing of Eggerthella lenta blood culture isolates at a university hospital in Belgium from 2004 to 2018.
Declerck B; Van der Beken Y; De Geyter D; Piérard D; Wybo I
Anaerobe; 2021 Jun; 69():102348. PubMed ID: 33596468
[TBL] [Abstract][Full Text] [Related]
4. Identification and Antibiotic Susceptibility of
Li X; Xu E; Shi C; Qiao G; Chen S; Xu Y; Liu Y; Bao X
Pol J Microbiol; 2022 Jun; 71(2):257-261. PubMed ID: 35716165
[TBL] [Abstract][Full Text] [Related]
5. Microbiological diagnosis of Eggerthella lenta blood culture isolates in a Swedish tertiary hospital: Rapid identification and antimicrobial susceptibility profile.
Liderot K; Ratcliffe P; Lüthje P; Thidholm E; Özenci V
Anaerobe; 2016 Apr; 38():21-24. PubMed ID: 26612006
[TBL] [Abstract][Full Text] [Related]
6.
Bo J; Wang S; Bi Y; Ma S; Wang M; Du Z
Future Microbiol; 2020 Jul; 15():981-985. PubMed ID: 32815419
[No Abstract] [Full Text] [Related]
7. Clinical and microbiological characteristics of Eggerthella lenta bacteremia.
Gardiner BJ; Tai AY; Kotsanas D; Francis MJ; Roberts SA; Ballard SA; Junckerstorff RK; Korman TM
J Clin Microbiol; 2015 Feb; 53(2):626-35. PubMed ID: 25520446
[TBL] [Abstract][Full Text] [Related]
8. Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature.
Jiang S; E J; Wang D; Zou Y; Liu X; Xiao H; Wen Y; Chen Z
Eur J Med Res; 2021 Sep; 26(1):111. PubMed ID: 34544476
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia caused by Eggerthella lenta in an elderly man with a gastrointestinal malignancy: A case report.
Wong D; Aoki F; Rubinstein E
Can J Infect Dis Med Microbiol; 2014 Sep; 25(5):e85-6. PubMed ID: 25371694
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a university hospital in Taiwan from 2001 to 2010.
Lee MR; Huang YT; Liao CH; Chuang TY; Wang WJ; Lee SW; Lee LN; Hsueh PR
J Clin Microbiol; 2012 Jun; 50(6):2053-5. PubMed ID: 22495556
[TBL] [Abstract][Full Text] [Related]
12. Eggerthella lenta bacteremia in solid tumor cancer patients: Pathogen or witness of frailty?
Woerther PL; Antoun S; Chachaty E; Merad M
Anaerobe; 2017 Oct; 47():70-72. PubMed ID: 28442420
[TBL] [Abstract][Full Text] [Related]
13. Bacteremia Caused by the
Jiang J; She B; Zheng R
Infect Drug Resist; 2020; 13():3695-3698. PubMed ID: 33116689
[No Abstract] [Full Text] [Related]
14. Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
McKamey L; Venugopalan V; Cherabuddi K; Borgert S; Voils S; Shah K; Klinker KP
Int J Antimicrob Agents; 2018 Nov; 52(5):719-723. PubMed ID: 30125680
[TBL] [Abstract][Full Text] [Related]
15. A case of bacteremia caused by Dialister micraerophilus with Enterocloster clostridioformis and Eggerthella lenta in a patient with pyometra.
Kitagawa H; Tadera K; Omori K; Nomura T; Shigemoto N; Ohge H
BMC Infect Dis; 2024 Jan; 24(1):128. PubMed ID: 38267864
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013-2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations.
Rothe K; Wantia N; Spinner CD; Schneider J; Lahmer T; Waschulzik B; Schmid RM; Busch DH; Katchanov J
BMC Infect Dis; 2019 Dec; 19(1):1091. PubMed ID: 31888581
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological characteristics of Ruminococcus gnavus bacteremia and intra-abdominal infection.
Watanabe N; Watari T; Otsuka Y; Hosokawa N; Yamagata K; Fujioka M
Anaerobe; 2024 Feb; 85():102818. PubMed ID: 38211774
[TBL] [Abstract][Full Text] [Related]
18. Risk factor analysis for piperacillin-tazobactam-resistant Enterobacter spp. bacteremia at a tertiary hospital.
Yamairi K; Yamada K; Imoto W; Kuwabara G; Shibata W; Namikawa H; Oshima K; Nakaie K; Niki M; Kaneko Y; Kakeya H
Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115342. PubMed ID: 33735789
[TBL] [Abstract][Full Text] [Related]
19. Polymicrobial bloodstream infection with Eggerthella lenta and Desulfovibrio desulfuricans.
Liderot K; Larsson M; Boräng S; Ozenci V
J Clin Microbiol; 2010 Oct; 48(10):3810-2. PubMed ID: 20720029
[TBL] [Abstract][Full Text] [Related]
20. Postpartum endometritis and obstetrical sepsis associated with
Priputnevich T; Lyubasovskaya L; Muravieva V; Kondrakhin A; Ignateva A; Gordeev A; Shmakov R; Sukhikh G; Yarotskaya E
J Matern Fetal Neonatal Med; 2021 Jan; 34(2):313-317. PubMed ID: 30975002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
